Rohto Pharmaceutical Co Ltd 2022 Integrated Report
Company: Rohto Pharmaceutical Co Ltd
Sector: Manufacturing
Country: Japan
Year: 2022
Type: Integrated Report
Pages: 41
The report presents Rohto's well-being-centered Vision 2030 across six business domains and reports fiscal 2021 consolidated net sales of 199.6 billion yen and operating income of 29.3 billion yen. It identifies five materialities and describes the Sustainability Committee's role in promoting sustainability initiatives. The report also sets out a Scope 1 and 2 emissions reduction target of 46% by fiscal 2030 from fiscal 2013; this target is explicitly identified as non-consolidated.
Services
From bulk PDFs to structured indicators and machine-readable documents.